Post-marketing research about Distreptaza

From March till April 2014 In Mongolia was held post-marketing research for obstetrician-gynecologists doctors about Distreptaza. Doctors have prescribed the product Distreptaza to women with inflammatory diseases of the pelvic organs and evaluated the efficacy and safety of the product. Distreptaza is a unique product that conquers inflammation, adhesions and infertility! Distreptaza is made in Poland and supplied by the company “Alpen Pharma Group” on the pharmaceutical market of Mongolia. For each patient, to whom was appointed Distreptaza, was filled a special questionnaire in which were recorded the following indicators: the elimination of pain, elimination of inflammation, if there were observed any side effects etc. More than 50 doctors were involved in this research, which upon completion of the research were awarded with memorable gifts.